




These amendments to the New Drugs and Clinical Trials Rules will come into force in March
Approval clears the regulatory path for a lower-cost GLP-1 weight-loss drug in India, but commercial launch hinges on semaglutide patent expiry.
The Supreme Court has held that all the daughters who were alive on September 9, 2005 are to be treated as coparceners of the HUF and are entitled to a share in the HUF property